Abstract. Cardiomyocyte apoptosis is closely associated with the pathogenesis of heart failure. Jujuboside A (JUA) is a type of saponin isolated from the seeds of Zizyphus jujuba. In traditional Chinese medicine, it is believed that JUA possesses multiple biological effects, including antianxiety, antioxidant and anti-inflammatory activities. The present study aimed to evaluate the effects of JUA on norepinephrine (NE)-induced apoptosis of H9c2 cells and to investigate its underlying mechanisms. Rat H9c2 cardiomyocytes were pretreated with JUA and were then exposed to NE as an in vitro model of myocardial apoptosis. A cell viability assay, scanning electron microscopy, transmission electron microscopy, flow cytometry assay, acridine orange/ethidium bromide staining, reverse transcription-quantitative polymerase chain reaction and western blotting, all revealed that NE induced H9c2 cell apoptosis. The results demonstrated that NE inhibited cell viability, and enhanced cell damage and apoptosis of H9c2 cells. Conversely, pretreatment with JUA was able to reverse NE-induced decreased cell viability and increased apoptosis. Furthermore, JUA suppressed upregulation of the B-cell lymphoma 2 (Bcl-2)-associated X protein/Bcl-2 ratio, and inhibited the increased protein expression levels of cleaved caspase-3 and cleaved caspase-9 following NE exposure. However, the protein expression levels of cleaved caspase-12 and cleaved caspase-8 were not significantly altered following exposure to NE or JUA pretreatment. In addition, in JUA-pretreated cells, the protein expression levels of phosphorylated (p)-p38 and p-c-Jun N-terminal kinase were downregulated compared with in NE-treated cells. Furthermore, JUA regulated the activation of extracellular signal-regulated kinase (ERK) in NE-treated cells and significantly increased the expression levels of p-AKT. Taken together, these data suggested that JUA may protect against NE-induced apoptosis of cardiomyocytes via modulation of the mitogen-activated protein kinase and AKT signaling pathways. Therefore, JUA may be considered a potential therapeutic strategy for the treatment of heart disease.
Introduction
Enhanced activity of the sympathetic nervous system in the myocardium is an important feature of heart failure (1). Notably, a significant loss of cardiomyocytes by apoptosis is a major pathogenic feature of various cardiovascular diseases, including heart failure, myocardial ischemia and infarction (2) . Norepinephrine (NE), which is the primary transmitter in the sympathetic nervous system, has been demonstrated to induce apoptosis of adult and neonatal rat cardiomyocytes (3) . Enhancement of cardiac sympathetic nerve activity in myocardial ischemia elicits the release of NE from nerve endings (4) . NE-induced apoptosis of cardiomyocytes is closely associated with heart failure (5,6). Our previous study indicated that transport stress resulted in an increase in NE and mitochondrial apoptosis (7) . Therefore, in the present study, NE was used to stimulate H9c2 cells to explore the underlying mechanism of apoptosis.
Spina date seed (SZS), which is the mature seed of Ziziphus jujuba Mill. var. spinosa (Bunge) Hu ex H.F. Chow, is traditionally used as a folk medicine, due to its anti-anxiety activity (8) . Jujuboside A (JUA) is a classic natural product extracted from SZS, which has been demonstrated to be the most effective pharmacological active component of SZS (9) . Previous studies have reported that JUA exerts antioxidant, anti-anxiety, anti-inflammatory and hypnotic-sedative activities, and is able to reduce cell apoptosis (10, 11) . Our previous study indicated that JUA could markedly reduce the damage caused by isoproterenol via activating the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin pathway (12) . However, to the best of our knowledge, no previous studies have focused on the protective effects of JUA on NE-induced cardiomyocyte apoptosis. The present study aimed to examine the protective effects of JUA on H9c2 cardiomyocytes against NE-induced apoptosis in vitro, in order to elucidate the underlying mechanism of JUA. The present study investigated JUA-mediated protection against NE-induced apoptosis, and the involvement of the mitogen-activated protein kinase (MAPK) and AKT signaling pathways. Cell culture and treatment. H9c2 cells were purchased from the Cell Resource Center of Chinese Academy of Medical Sciences (Peking Union Medical College, Beijing, China). Cells were cultured in DMEM supplemented with 10% FBS and antibiotics (100 U/ml penicillin and 100 U/ml streptomycin) at 37˚C in a humidified atmosphere containing 5% CO 2 . The cells were subcultured with 0.05% trypsin (Gibco; Thermo Fisher Scientific, Inc.). JUA and NE were diluted in DMEM. H9c2 cells were washed with phosphate-buffered saline (PBS) twice and serum-starved for 2 h prior to incubation with JUA or NE.
Materials and methods

Reagents
Cell viability assay. Cell viability was determined using the MTT reduction assay as previously described (12) . Briefly, H9c2 cells were preincubated with DMEM containing 10% FBS overnight in 96-well plates at a density of 5x10 4 cells/well. 
Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptotic analysis.
Cellular apoptosis was determined using the Annexin V-FITC/PI cell apoptosis detection kit (Thermo Fisher Scientific, Inc.). Following treatment, the cells were harvested by trypsinization, washed twice with cold PBS and were centrifuged at 1,200 x g for 10 min at 4˚C. Cells were resuspended in 100 µl 1X binding buffer and were transferred to a sterile flow cytometry glass tube. Subsequently, 5 µl Annexin V-FITC and 5 µl propidium iodide were added and incubated at room temperature (25˚C) in the dark for 15 min. Finally, detection was performed by flow cytometry (Beckman Coulter, Inc., Brea, CA, USA) according to the manufacturer's protocol, and data was analyzed using FCS Express software (version 3.0; De Novo Software, Glendale, CA, USA).
Acridine orange (AO)/ethidium bromide (EB) staining.
The apoptotic morphology of H9c2 cells was detected by staining the cells with a combination of the fluorescent DNA-binding dyes AO and EB (100 µg/ml each in PBS; Sigma-Aldrich; Merck KGaA) for 15 min at room temperature. Subsequently, the cells were observed under a fluorescence microscope (IX71/IX2; Olympus Corporation).
RNA extraction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis.
Total RNA was isolated from H9c2 cells using the phenol and guanidine isothiocyanate-based TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.). RNA concentration and purity were determined using a spectrophotometer (SmartSpec Plus; Bio-Rad Laboratories, Inc.) based on the ratios of optical density (OD) 260 /OD 280 and OD 260 /OD 230 . Total mRNA was reverse transcribed using the iScript cDNA synthesis kit (Promega Corporation, Madison, WI, USA) according to the manufacturer's protocol. The expression levels of Bax and Bcl-2 were determined by qPCR analysis using the DNA Engine Mx3000P ® fluorescence detection system (Stratagene; Agilent Technologies, Inc., Santa Clara, CA, USA). The designed paired primers were as follows: β-actin, forward 5'-CCT GCG GCA TTC ACG AAA CTA C-3' and reverse 5'-ACT CCT GCT TGC TGA TCC ACA TC-3'; B-cell lymphoma 2(Bcl-2)-associated X protein (Bax), forward 5'-CAG GAC GCA TCC ACC AAG AA-3', reverse 5'-GGG TCC CGA AGT AGG AAA GG-3'; and Bcl-2, forward 5'-CTG GGA GAA CAG GGT ATG-3' and reverse 5'-CGT AGA AGA GGA GGG TC-3'. RT-qPCR analysis was performed using the SYBR PrimeScript™ RT-PCR kit (Takara Biotechnology Co., Ltd., Dalian, China). The thermocycling conditions were as follows: 94˚C for 5 min, followed by 40 cycles of 94˚C for 10 sec, 60˚C for 20 sec and 72˚C for 60 sec. RNA expression was quantified using the 2 -ΔΔCq relative quantification method (13) .
Western blot analysis. Protein was extracted from the cells using a total protein extraction kit (Biochain Institute, Inc., Newark, CA, USA), and was quantified using a BCA protein assay kit according to the manufacturer's protocol. Proteins (20 µg) were separated by 12% SDS-PAGE and were transferred to nitrocellulose membranes (Pierce; Thermo Fisher Scientific, Inc.). Subsequently, membranes were blocked with SuperBlock T20 (TBS) blocking buffer (cat. no. 37536, Pierce, USA) for 2.5 h at room temperature, and were then incubated overnight at 4˚C with the specific primary antibodies to GAPDH (1:1,000), JNK (1:1,000), p-JNK (1:1,000), p38 (1:1,000), p-p38 (1:1,000), ERK (1:1,000), p-ERK (1:2,000), AKT (1:1,000), p-AKT (1:2,000), cleaved caspase-3 (1:1,000), cleaved caspase-8 (1:1,000), cleaved caspase-9 (1:1,000) and cleaved caspase-12 (1:1,000). The membranes were then incubated with the secondary antibody (1:15,000) for 1 h at room temperature. Subsequently, the blots were visualized and analyzed using the Odyssey Infrared Imaging system (LI-COR Biotechnology). Blots were normalized to GAPDH and were semi-quantified using ImageJ version 2.1.4.7 software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. Data are presented as the mean ± standard error of the mean of at least three independent experiments. The results were analyzed by one-way analysis of variance followed by Duncan's test for multiple comparisons using SPSS 19 .0 (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
NE inhibits cell viability, enhances apoptosis and induces morphological alterations in H9c2 cells.
H9c2 cells were treated with various concentrations of NE for 0, 6, 12, and 18 h. The results of an MTT assay demonstrated that the number of viable cells decreased in response to the increased concentration and duration of NE treatment. (Fig. 1A) . Following stimulation with 20 or 50 µM NE for 6 h, cell viability was significantly inhibited (P<0.05; Fig. 1A) . A more marked decrease (P<0.01; Fig. 1A ) in cell viability occurred following treatment with NE for 12 or 18 h. Furthermore, flow cytometric analysis demonstrated that the apoptotic rate of H9c2 cells was increased following treatment with 5 µM NE for 12 h (Fig. 1B) . As observed under SEM, NE-treated cells exhibited an abnormal cellular microstructure, which was characterized by irregular-arranged cell shape, sparser cell surface and increased nuclear gap (Fig. 1C) . Electron microscopy analysis of H9c2 cells revealed marked alterations in the structure of cardiomyocytes and the cellular architecture. Ultrastructural images of H9c2 cells using TEM showed obvious nuclear chromatin margination, aggregation, condensation, and mitochondrial vacuolization in NE-treated cells (Fig. 1D ). According to these results, treatment with 5 µM NE for 12 h was selected for the generation of an in vivo model of H9c2 cell damage.
Cytotoxic effects of JUA on H9c2 cells. H9c2 cells were treated with various concentrations of JUA (0, 2, 5, 10, 20, 50 and 100 µM) for 24, 48 and 72 h. Cell viability was determined using an MTT assay. The results demonstrated that treatment with between 0 and 100 µM JUA had no cytotoxic effect on H9c2 cells (Fig. 2) .
JUA improves cell viability and reduces H9c2 apoptosis following NE exposure.
The results of an MTT assay demonstrated that JUA significantly enhanced the survival rate of the cells following exposure to NE (Fig. 3A) . In addition, flow cytometry indicated that JUA reduced apoptosis in a dose-dependent manner at 12 h following NE exposure ( Fig. 3B and C) . Pretreatment with JUA was also revealed to alleviate the apoptotic response in H9c2 cells following treatment with NE, as determined by AO and EB staining (Fig. 3D) .
JUA initially upregulates the Bax/Bcl-2 ratio and then downregulates the ratio following treatment of H9c2 cells with NE.
The results of an RT-qPCR demonstrated that the mRNA expression levels of Bax were upregulated following exposure to NE for 3 and 6 h; this effect was markedly inhibited by JUA (Fig. 4A ). In addition, pretreatment with JUA was able to downregulate the mRNA expression levels of Bcl-2 at 3 and 6 h following NE exposure, and upregulate the mRNA expression levels of Bcl-2 at 9 and 12 h following NE exposure (Fig. 4B) . Correspondingly, the ratio of Bax/Bcl-2 in JUA-pretreated cells was increased following exposure to NE for 3 and 6 h (with all JUA pretreatments), and was decreased after exposure to NE for 9 h (with all JUA pretreatments) and 12 h (5 and 20 µM JUA pretreatments only). However, the Bax/Bcl-2 ratio increased following JUA (10 µM) pretreatment and NE incubation for 12 h (Fig. 4C) . With the prolonged incubation time with NE, the mRNA expression levels of the anti-apoptotic gene Bcl-2 were downregulated, whereas the expression levels of the proapoptotic gene Bax were upregulated, thus suggesting that JUA may exert its anti-apoptotic effect by regulating the ratio of Bax/Bcl-2.
JUA inhibits NE-induced cleaved caspase-3 and cleaved caspase-9 protein expression in H9c2 cells.
Western blotting revealed that the protein expression levels of cleaved caspase-3 and cleaved caspase-9 were significantly increased in cells treated with NE for 6 and 12 h, whereas pretreatment with JUA significantly decreased the protein expression levels of cleaved caspase-3 and cleaved caspase-9 in the cells (Fig. 5A-C) . However, the protein expression levels of cleaved caspase-12 and cleaved caspase-8 were not significantly altered following exposure to NE or JUA pretreatment (Fig. 5A, D and E) , thus indicating that JUA may alleviate NE-induced apoptosis via the mitochondrial-dependent pathway in H9c2 cardiomyocytes.
JUA reduces NE-induced apoptosis via influencing MAPK and AKT signals in H9c2 cells.
To further elucidate the signaling pathways by which JUA exerts its anti-apoptotic effects, the activation of MAPK and AKT were examined. Western blotting results demonstrated that the expression levels of p-JNK and p-p38 were significantly increased following exposure to NE for 6 and 12 h. Conversely, pretreatment with JUA was able to reduce the expression levels of p-JNK and p-p38 at 6 or 12 h following NE exposure (Fig. 6A-C) . In addition, the expression levels of p-ERK were significantly increased following treatment with NE. Pretreatment with JUA significantly reduced the expression levels of p-ERK at 6 h following NE exposure. However, in cells pretreated with 20 µM JUA, the expression levels of p-ERK were significantly increased at 12 h following NE exposure ( Fig. 6A and D) . Furthermore, in the groups receiving 10 and 20 µM JUA, the expression levels of p-AKT were significantly increased at 6 or 12 h following NE exposure (Fig. 6A and E) . The total expression levels of JNK, p38, ERK and AKT were not significantly altered following exposure to NE or JUA pretreatment.
Discussion
The majority of in vitro and in vivo studies have demonstrated that NE-induced cardiotoxicity is a major mediator of the biochemical alterations leading to cardiomyocyte apoptosis and necrosis (14) (15) (16) (17) . Our previous study revealed that increased plasma NE and epinephrine levels in stress-induced rats promoted myocardial damage and cardiac dysfunction (6) . Therefore, the present study exposed H9c2 cells to NE, and subsequently assessed cell viability, apoptosis and the morphological alterations of H9c2 cell microstructure. The results demonstrated that the survival rate of H9c2 cells was decreased in a time-and dose-dependent manner following exposure to NE. Furthermore, marked NE-induced cell damage and apoptosis were detected in H9c2 cells. These findings verified that NE induced cell damage and apoptosis of H9c2 cells.
JUA is a natural product isolated from the seeds of Zizyphus jujuba, which possesses numerous biological effects (8) . Previous studies have reported that JUA exerts anti-injury effects, and neuroprotective and cardioprotective activity via antioxidative and anti-inflammatory effects in animal models of dementia (10, 12, 18, 19) . In the present study, the results of an MTT assay indicated that JUA (0-100 µM) did not exhibit a cytotoxic effect on H9c2 cells. Furthermore, JUA effectively reversed the decreased cell viability caused by NE and reduced NE-induced H9c2 cell apoptosis. It has previously been reported that NE may induce cell apoptosis through activating the Bax/Bcl-extra large/caspase-3 pathway, the Bcl-2/caspase-2 pathway, the β-adrenergic pathway and the p38 MAPK pathway (3, 20) . The present study confirmed that NE activated the p38 MAPK pathway, which was consistent with previous research (21) . In addition, the Bax and Bcl-2 mRNA expression levels were detected in the present study. Bax is a proapoptotic member of the Bcl-2 protein family that resides in the outer mitochondrial membrane (22) . A change in the Bax/Bcl-2 ratio may contribute to an increase in caspase-3 activity via the release of cytochrome c from the mitochondria (23) . The release of cytochrome c initiates the deoxyadenosine triphosphate-dependent oligomerization of apoptotic protease activating factor 1 and caspase-9 to form the apoptosome, which can further activate effector caspase-3, resulting in cell apoptosis (24) . The present study revealed that the Bax/Bcl-2 ratio was not significantly altered at 3 and 6 h following NE exposure, however, it was upregulated at 9 and 12 h following NE exposure. This regulation was attenuated by JUA, with exception to cells pretreated with 10 µM JUA and NE for 12 h, which produced a significant increase in the Bax/Bcl-2 ratio when compared with the NE group. The increase in the Bax/Bcl-2 ratio observed in cells treated with NE for 9 and 12 h indicated that H9c2 cell apoptosis may occur over a long period time. In addition, JUA reversed NE-induced increases in the protein expression levels of cleaved caspase-3 and cleaved caspase-9, whereas the protein expression levels of cleaved caspase-8 and cleaved caspase-12 were not significantly altered. Bax/Bcl-2, cleaved caspase-3 and cleaved caspase-9 have been reported to serve important roles in the mitochondrial apoptotic pathway; however, cleaved caspase-8 and cleaved caspase-12 are key proteins in the death receptor signaling pathway and endoplasmic reticulum apoptotic pathway, respectively (25) (26) (27) (28) . The results of the present study suggested that the anti-apoptotic effects of JUA may be mediated through the mitochondrial-dependent apoptotic pathway.
MAPKs regulate various cellular responses to environmental stimuli, including cell survival, transformation and apoptosis, and serve important roles in cardiomyocyte apoptosis (29) (30) (31) . ERK protects cardiomyocytes from apoptosis, whereas p38 MAPK is involved in the induction of cardiomyocyte apoptosis (32, 33) . Furthermore, JNK signaling exerts pro-and anti-apoptotic effects; however, the proapoptotic effects appear to be most dominant in the majority of experimental models (34, 35) . AKT exerts direct effects on apoptosis, and AKT activation is able to suppress the apoptotic effects of activated JNK and P38 MAPK signaling pathways (36) . In addition, AKT has been reported to be involved in apoptosis and endoplasmic reticulum stress in the rat small intestine (37) . Furthermore, JNK has been reported to negatively regulate AKT activation (38) . The present study indicated that NE upregulated p-JNK and p-p38 expression in H9c2 cells, and that this regulation was attenuated by JUA. Treatment with NE for 6 h also upregulated p-AKT expression, however, JUA pretreatment further increased expression. Conversely, ERK was inhibited in JUA-pretreated cells at 6 h following NE exposure, whereas it was activated at 12 h following NE exposure, which suggested that JUA may attenuate the upregulation of ERK induced by NE during the early stages and ERK may adaptively respond to NE treatment in these short time periods. These results indicated that JUA may reduce NE-induced apoptosis by inhibiting the JNK and p38 signaling pathways, regulating the ERK pathway and activating the AKT pathway in H9c2 cells.
In conclusion, the present study provided a feasible molecular explanation regarding the inhibitory effects of JUA on NE-induced apoptosis of H9c2 cells, which may offer a therapeutic option for preventing NE-induced heart failure. Further investigations are required to elucidate the precise mechanisms underlying the protective effects of JUA on cardiomyocyte apoptosis.
